Skip to main content

Table 3 Odds ratios and 95% confidence intervals for breast cancer risk associated with BsmI and Poly(A) genotypes, stratified by race and menopausal status

From: Vitamin D receptor polymorphisms and breast cancer risk in a large population-based case-control study of Caucasian and African-American women

Genotype   Menopausal status Caucasian African-American
    Case (%) Control (%) ORa (95% CI) Case (%) Control (%) ORa (95% CI)
BsmI B/B Premenopausal 164 (25.3) 133 (25.8) 1.0 (referent) 38 (12.1) 22 (9.6) 1.0 (referent)
  B/b   244 (36.9) 198 (36.0) 1.1 (0.8 to 1.5) 108 (34.6) 90 (36.7) 0.8 (0.4 to 1.4)
  b/b   247 (37.8) 199 (38.1) 1.0 (0.7 to 1.4) 156 (53.3) 126 (53.7) 0.8 (0.4 to 1.5)
  Any b   491 (74.7) 397 (74.2) 1.0 (0.8 to 1.4) 264 (87.9) 216 (90.4) 0.8 (0.4 to 1.4)
  B/B Postmenopausal 114 (23.5) 125 (29.2) 1.0 (referent) 29 (15.2) 28 (14.3) 1.0 (referent)
  B/b   188 (39.3) 173 (40.9) 1.2 (0.8 to 1.8) 66 (38.0) 78 (34.0) 1.0 (0.5 to 2.0)
  b/b   179 (37.2) 137 (30.0) 1.5 (1.0 to 2.3)b 88 (46.8) 102 (51.7) 0.9 (0.5 to 2.0)
  Any b   367 (76.5) 310 (70.8) 1.4 (1.0 to 1.9) 154 (84.8) 180 (85.7) 1.0 (0.5 to 1.8)
Poly(A) S/S Premenopausal 98 (15.7) 79 (15.4) 1.0 (referent) 23 (9.1) 14 (6.8) 1.0 (referent)
  L/S   303 (45.3) 260 (47.3) 0.9 (0.6 to 1.4) 109 (39.6) 88 (39.2) 0.8 (0.4 to 1.7)
  L/L   256 (39) 203 (37.3) 1.0 (0.7 to 1.5) 144 (51.3) 118 (54.1) 0.7 (0.3 to 1.6)
  Any L   559 (84.3) 463 (84.6) 1.0 (0.7 to 1.4) 253 (90.9) 206 (93.3) 0.7 (0.4 to 1.6)
  S/S Postmenopausal 69 (14.5) 70 (15.8) 1.0 (referent) 12 (8.5) 13 (6.8) 1.0 (referent)
  L/S   229 (47.2) 222 (52.2) 1.0 (0.7 to 1.6) 72 (41.9) 81 (38.9) 0.8 (0.3 to 2.1)
  L/L   184 (38.3) 151 (31.9) 1.3 (0.9 to 2.1) 81 (49.5) 103 (54.3) 0.8 (0.3 to 2.1)
  Any L   413 (85.5) 373 (84.2) 1.2 (0.8 to 1.8) 153 (91.5) 184 (93.2) 0.8 (0.3 to 2.0)
  1. aOdds ratio (OR) adjusted for age, race, study site, and sampling weights. bP for trend <0.05.